title: Tuning the rigging before sailing off into the stormy sea of stem cell transplants for patients with myelodysplastic syndromes.
authors.affiliation: Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. david_steensma@dfci.harvard.edu
authors.forename: David P
authors.initials: DP
authors.lastname: Steensma
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D001374:Azacitidine